https://www.mesothelioma-line.com/impact-of-guideline-therapy-on-survival-of-patients-with-stage-i-iii-epithelioid-mesothelioma/ 2024-02-19T22:23:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-of-mesothelioma-the-evolving-change-of-a-long-standing-therapeutic-dream/ 2024-02-19T22:35:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-of-attempted-transbronchial-spigot-insertion-for-fistulous-pyothorax-in-the-residual-pleural-airspace-after-pleurectomy-decortication-for-malignant-pleural-mesothelioma/ 2024-02-26T17:37:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-and-pathological-observation-of-conversion-therapy-for-malignant-peritoneal-mesothelioma-a-case-report-and-literature-review/ 2024-02-26T18:17:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-wilms-tumor-1-and-calretinin-in-predicting-survival-and-response-to-first-line-chemotherapy-in-patients-with-pleural-mesothelioma/ 2024-02-26T21:14:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/is-extereme-cytoreductive-surgery-beneficial-to-survival-in-malignant-peritoneal-mesothelioma/ 2024-02-26T21:25:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/mononeuritis-multiplex-following-immune-checkpoint-inhibitors-in-malignant-pleural-mesothelioma/ 2024-02-26T21:42:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/detailed-clinical-course-of-a-patient-with-rapidly-progressing-sarcomatoid-pleural-mesothelioma-without-p16-deletion-with-systemic-haematogenous-metastasis-to-soft-tissues/ 2024-03-04T16:51:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/three-dimensional-printing-of-the-human-lung-pleural-cavity-model-for-pdt-malignant-mesothelioma/ 2024-03-04T17:28:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/pegargiminase-plus-first-line-chemotherapy-in-patients-with-nonepithelioid-pleural-mesothelioma-the-atomic-meso-randomized-clinical-trial/ 2024-03-04T20:32:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/nivolumab-in-pretreated-pleural-mesothelioma-results-from-an-observational-real-world-study-of-patients-treated-within-the-aifa-5-fund/ 2024-03-04T20:48:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/venous-thromboembolism-in-peritoneal-mesothelioma-uncovering-the-hidden-risk/ 2024-03-04T20:58:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/involvement-of-palliative-care-in-malignant-pleural-mesothelioma-patients-and-associations-with-survival-and-end-of-life-outcomes/ 2024-03-11T15:40:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-impact-of-3d-nichoids-and-matrix-stiffness-on-primary-malignant-mesothelioma-cells/ 2024-03-11T15:47:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/chst4-gene-as-a-potential-predictor-of-clinical-outcome-in-malignant-pleural-mesothelioma/ 2024-03-11T16:29:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-genetic-susceptibility-in-the-development-of-malignant-pleural-mesothelioma-somatic-and-germline-variants-clinicopathological-features-and-implication-in-practical-medical-surgical-care-a-narra/ 2024-03-11T16:41:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-highly-selective-and-oral-phosphoinositide-3-kinase-delta-pi3k-%ce%b4-inhibitor-roginolisib-induces-apoptosis-in-mesothelioma-cells-and-increases-immune-effector-cell-composition/ 2024-03-11T19:36:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/successful-treatment-of-simultaneous-malignant-pleural-mesothelioma-and-pulmonary-adenocarcinoma-a-case-report/ 2024-03-18T15:23:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/pold1-is-required-for-cell-cycle-progression-by-overcoming-dna-damage-in-malignant-pleural-mesothelioma/ 2024-03-18T17:04:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/uv1-telomerase-vaccine-with-ipilimumab-and-nivolumab-as-second-line-treatment-for-pleural-mesothelioma-a-phase-ii-randomised-trial/ 2024-03-18T17:24:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-mesothelioma-pme-the-evolving-molecular-knowledge-of-a-rare-and-aggressive-cancer/ 2024-03-18T19:07:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-gene-signature-linked-to-fibroblast-differentiation-for-prognostic-prediction-of-mesothelioma/ 2024-03-18T19:19:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/immune-modulation-in-malignant-pleural-effusion-from-microenvironment-to-therapeutic-implications/ 2024-03-25T14:50:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/complex-genomic-rearrangement-patterns-in-malignant-pleural-mesothelioma-due-to-environmental-asbestos-exposure/ 2024-03-25T19:04:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/peritoneal-malignant-mesothelioma-metastasizing-to-lymph-node-in-young-male-a-case-report/ 2024-03-25T19:12:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/characterization-of-klhl14-anti-oncogenic-action-in-malignant-mesothelioma/ 2024-03-25T19:23:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/investigation-of-the-appropriate-viscosity-of-fibrinogen-in-repairing-pleural-defects-using-ventilation-and-anchoring-in-an-ex-vivo-pig-model/ 2024-03-25T19:53:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/reliably-making-the-primary-diagnosis-of-mesothelioma-utilizing-serous-fluid-cytology-specimens-an-institutional-experience/ 2024-04-01T18:34:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-iaslc-mesothelioma-staging-project-proposals-for-revisions-of-the-t-descriptors-in-the-forthcoming-9th-edition-of-the-tnm-classification-for-pleural-mesothelioma/ 2024-04-01T18:40:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/combination-of-ezh2-and-atm-inhibition-in-bap1-deficient-mesothelioma/ 2024-04-01T19:08:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-mental-health-and-well-being-implications-of-a-mesothelioma-diagnosis-a-mixed-methods-study/ 2024-04-01T19:15:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/characterization-of-pleural-mesothelioma-by-hierarchical-clustering-analyses-using-immune-cells-within-tumor-microenvironment/ 2024-04-01T19:28:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/characterization-of-pleural-mesothelioma-by-hierarchical-clustering-analyses-using-immune-cells-within-tumor-microenvironment-2/ 2024-04-08T18:00:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/kinetically-controlled-polyelectrolyte-complex-assembly-of-microrna-peptide-nanoparticles-toward-treating-mesothelioma/ 2024-04-08T18:11:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/implementation-of-a-high-resolution-high-contrast-magnetic-resonance-imaging-protocol-with-extended-delayed-phases-for-peritoneal-mesothelioma/ 2024-04-08T18:21:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-mesothelioma-in-situ-a-comprehensive-review/ 2024-04-08T20:05:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/establishing-mesothelioma-patient-derived-organoid-models-from-malignant-pleural-effusions/ 2024-04-08T20:28:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-significance-of-inflammation-scores-in-malignant-mesothelioma/ 2024-04-15T15:49:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/guidelines-for-pathologic-diagnosis-of-mesothelioma/ 2024-04-15T18:06:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/patients-with-mesothelioma-and-their-carers-experience-of-diet-and-appetite-a-qualitative-insight-from-the-help-meso-study/ 2024-04-15T18:28:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-cytoreductive-surgery-and-hipec-for-the-treatment-of-primary-and-secondary-peritoneal-malignancies-experience-from-a-tertiary-care-center-in-germany/ 2024-04-15T21:04:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/low-exposures-to-amphibole-or-serpentine-asbestos-in-germline-bap1-mutant-mice-induce-mesothelioma-characterized-by-an-immunosuppressive-tumor-microenvironment/ 2024-04-15T21:18:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-performance-of-immunohistochemistry-markers-for-malignant-pleural-mesothelioma-diagnosis-and-subtypes-a-systematic-review-and-meta-analysis/ 2024-04-22T16:55:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/yap-taz-tead-signalling-axis-a-new-therapeutic-target-in-malignant-pleural-mesothelioma/ 2024-04-22T17:10:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-mobility-group-box-1-mediates-inflammatory-responses-in-malignant-peritoneal-mesothelioma/ 2024-04-22T19:07:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/emerging-new-targets-in-systemic-therapy-for-malignant-pleural-mesothelioma/ 2024-04-22T19:44:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-of-patient-and-caregiver-conceptual-models-investigating-the-health-related-quality-of-life-impacts-of-malignant-pleural-mesothelioma/ 2024-04-22T19:59:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/circulating-smrp-and-ca-125-before-and-after-pleurectomy-decortication-for-pleural-mesothelioma/ 2024-04-29T16:26:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/diffuse-pleural-mesotheliomas-with-genomic-near-haploidization-a-newly-recognized-subset-with-distinct-clinical-histologic-and-molecular-features/ 2024-04-29T16:59:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/risk-factors-influencing-postoperative-pleural-empyema-in-patients-with-pleural-mesothelioma-a-retrospective-single-centre-analysis/ 2024-04-29T17:07:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-characterization-and-detection-of-potential-therapeutic-targets-for-peritoneal-mesothelioma-in-current-practice/ 2024-04-29T17:31:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/advances-in-immunotherapy-for-malignant-pleural-mesothelioma-from-emerging-strategies-to-translational-insights/ 2024-04-29T18:06:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/advances-in-immunotherapy-for-malignant-pleural-mesothelioma-from-emerging-strategies-to-translational-insights-2/ 2024-05-06T17:27:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-first-line-and-salvage-therapies-for-unresectable-malignant-mesothelioma-a-systematic-review-and-network-meta-analysis/ 2024-05-06T17:50:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/multimodal-treatment-of-pleural-mesothelioma-with-cytoreductive-surgery-and-hyperthermic-intrathoracic-chemotherapy-impact-of-additive-chemotherapy/ 2024-05-06T19:07:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-mesothelioma-from-fluoro-edenite-exposure-pacap-and-pac1-receptor-a-preliminary-report/ 2024-05-06T19:33:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/aerostasis-to-limit-air-leak-following-extended-pleurectomy-decortication/ 2024-05-06T20:08:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/time-course-rnaseq-data-of-murine-ab1-mesothelioma-and-renca-renal-cancer-following-immune-checkpoint-therapy/ 2024-05-13T17:01:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-deficiency-inflames-the-tumor-immune-microenvironment-and-is-a-candidate-biomarker-for-immunotherapy-response-in-malignant-pleural-mesothelioma/ 2024-05-13T17:14:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-peritoneal-mesothelioma-presenting-with-bilateral-hydronephrosis-and-renal-insufficiency-a-case-report-and-literature-review/ 2024-05-13T17:19:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-accuracy-of-ultrasound-guided-percutaneous-pleural-needle-biopsy-for-malignant-pleural-mesothelioma/ 2024-05-13T20:38:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/differential-expression-of-dmd-transcripts-as-a-novel-prognostic-biomarker-in-histologically-diverse-mesotheliomas/ 2024-05-13T21:00:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/leveraging-the-pleural-space-for-anticancer-therapies-in-pleural-mesothelioma/ 2024-05-20T18:28:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/extended-pleurectomy-decortication-and-chemotherapy-versus-chemotherapy-alone-for-pleural-mesothelioma-mars-2-a-phase-3-randomised-controlled-trial/ 2024-05-20T18:48:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/differential-expression-of-dmd-transcripts-as-a-novel-prognostic-biomarker-in-histologically-diverse-mesotheliomas-2/ 2024-05-20T19:12:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-systematic-review-of-minimally-invasive-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-in-patients-with-peritoneal-malignancy/ 2024-05-20T19:43:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/comprehensive-genomic-profiling-of-pediatric-peritoneal-mesothelioma-case-report-with-a-literature-review/ 2024-05-20T20:49:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-inflammatory-factors-for-chemoprevention-and-cancer-interception-to-tackle-malignant-mesothelioma/ 2024-05-28T20:51:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/concordance-between-cdkn2a-homozygous-deletion-and-mtap-immunohistochemical-loss-in-fluoroedenite-induced-pleural-mesothelioma-an-immunohistochemical-and-molecular-study-on-a-single-institution-serie/ 2024-05-28T20:56:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-inflammatory-factors-for-chemoprevention-and-cancer-interception-to-tackle-malignant-mesothelioma-2/ 2024-06-03T17:39:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/concordance-between-cdkn2a-homozygous-deletion-and-mtap-immunohistochemical-loss-in-fluoroedenite-induced-pleural-mesothelioma-an-immunohistochemical-and-molecular-study-on-a-single-institution-seri-2/ 2024-06-03T19:19:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-incidence-of-distant-metastases-in-patients-with-pleural-mesothelioma-screened-for-a-multimodal-approach-how-much-staging-do-we-really-need/ 2024-06-03T19:27:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/ki67-tumor-expression-predicts-treatment-benefit-achieved-by-macroscopic-radical-lung-preserving-surgery-in-pleural-mesothelioma-a-retrospective-multicenter-analysis/ 2024-06-03T19:35:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-associated-fibroblasts-modulate-the-response-of-mesothelioma-patient-derived-organoids-to-chemotherapy-via-interleukin-6/ 2024-06-03T19:50:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-and-t-cell-repertoire-biomarkers-associated-with-malignant-mesothelioma-survival/ 2024-06-10T18:05:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/analysis-of-treatment-strategies-and-outcomes-in-malignant-peritoneal-mesothelioma-insights-from-a-multi-center-study/ 2024-06-10T19:46:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/predictive-potential-of-mri-in-differentiating-the-predominant-component-in-biphasic-pleural-mesothelioma/ 2024-06-10T20:11:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/sarcomatoid-malignant-pleural-mesothelioma-a-case-of-long-term-recurrence-free-survival-following-curative-intent-surgery-alone/ 2024-06-10T20:19:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/fk228-suppress-the-growth-of-human-malignant-pleural-mesothelioma-tumor-independent-to-epithelioid-or-non-epithelioid-histology/ 2024-06-10T20:38:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-clinical-practices-of-cytoreductive-surgery-crs-and-hyperthermic-intraperitoneal-chemotherapy-hipec/ 2024-06-17T18:29:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-randomised-phase-ii-study-of-extended-pleurectomy-decortication-e-pd-preceded-or-followed-by-chemotherapy-in-patients-pts-with-early-stage-pleural-mesothelioma-pm-eortc-1205/ 2024-06-18T19:52:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparative-efficacy-of-immune-checkpoint-inhibitors-versus-chemotherapy-alone-in-diffuse-pleural-mesothelioma/ 2024-06-18T19:25:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/dendritic-cells-loaded-with-allogeneic-tumour-cell-lysate-plus-best-supportive-care-versus-best-supportive-care-alone-in-patients-with-pleural-mesothelioma-as-maintenance-therapy-after-chemotherapy-d/ 2024-06-18T20:42:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/immediate-versus-deferred-systemic-therapy-in-patients-with-mesothelioma/ 2024-06-18T20:43:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/dendritic-cells-loaded-with-allogeneic-tumour-cell-lysate-plus-best-supportive-care-versus-best-supportive-care-alone-in-patients-with-pleural-mesothelioma-as-maintenance-therapy-after-chemotherapy-2/ 2024-06-24T18:04:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/dual-malignancies-discovered-a-rare-case-of-malignant-peritoneal-epithelioid-mesothelioma-and-lung-adenocarcinoma/ 2024-06-24T19:33:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/comprehensive-pulmonary-rehabilitation-for-patients-with-malignant-pleural-mesothelioma-a-feasibility-pilot-study/ 2024-06-24T19:46:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-the-combination-of-gemcitabine-carboplatin-and-lactate-dehydrogenase-a-inhibitor-on-malignant-mesothelioma/ 2024-06-24T19:57:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-fdg-pet-ct-and-ct-for-evaluation-of-tumor-response-to-nivolumab-plus-ipilimumab-combination-therapy-and-prognosis-prediction-in-patients-with-unresectable-malignant-pleural-mesothelioma/ 2024-06-24T21:09:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/small-extracellular-vesicle-derived-circular-rna-hsa_circ_0007386-as-a-biomarker-for-the-diagnosis-of-pleural-mesothelioma/ 2024-07-01T17:27:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/optimal-isolation-of-extracellular-vesicles-from-pleural-fluid-and-profiling-of-their-microrna-cargo/ 2024-07-01T17:52:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/case-report-primary-malignant-mesothelioma-of-the-left-atrium-easily-misdiagnosed-as-myxoma/ 2024-07-01T18:02:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/review-on-treatment-of-pleural-metastasis-and-malignant-pleural-effusion-with-pressurized-intrathoracic-aerosol-chemotherapy-pitac/ 2024-07-01T19:37:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparative-analysis-of-genetic-variants-in-pleural-fluids-and-solid-tissue-biopsies-of-pleural-mesothelioma-patients-implications-for-molecular-heterogeneity-assessment/ 2024-07-01T19:49:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/thonzonium-bromide-inhibits-progression-of-malignant-pleural-mesothelioma-through-regulation-of-erk1-2-and-p38-pathways-and-mitochondrial-uncoupling/ 2024-07-08T18:01:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/fibroblast-activation-protein-directed-imaging-outperforms-18f-fdg-pet-ct-in-malignant-mesothelioma-a-prospective-single-center-observational-trial/ 2024-07-08T18:17:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/single-cell-view-of-tumor-microenvironment-gradients-in-pleural-mesothelioma/ 2024-07-08T18:25:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/real-world-efficacy-and-safety-of-combination-nivolumab-plus-ipilimumab-for-untreated-unresectable-pleural-mesothelioma-the-meso-immune-gfpc-04-2021-trial/ 2024-07-08T18:36:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/major-pathological-response-obtained-after-neoadjuvant-chemotherapy-combined-with-dual-immunotherapy-for-malignant-pleural-mesothelioma-a-case-report/ 2024-07-15T18:58:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-rare-case-of-a-huge-malignant-pleural-mesothelioma-presenting-in-the-posterior-mediastinum/ 2024-07-15T20:37:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/characterizing-soluble-immune-checkpoint-molecules-and-tgf-%ce%b2123-in-pleural-effusion-of-malignant-pleural-mesothelioma/ 2024-07-15T20:42:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/germline-bard1-variants-predispose-to-mesothelioma-by-impairing-dna-repair-and-calcium-signaling/ 2024-07-15T21:55:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-rare-case-of-pleural-epithelioid-mesothelioma-with-a-prominent-myxoid-stroma-reported-with-morphology-fluorescent-in-situ-hybridization-and-ultrastructural-findings/ 2024-07-15T22:08:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/pharmacological-inhibition-of-cdk4-6-impairs-diffuse-pleural-mesothelioma-3d-spheroid-growth-and-reduces-viability-of-cisplatin-resistant-cells/ 2024-07-22T17:58:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/integration-of-the-pd-l1-inhibitor-atezolizumab-and-wt1-dc-vaccination-into-standard-of-care-first-line-treatment-for-patients-with-epithelioid-malignant-pleural-mesothelioma-protocol-of-the-immuno-me/ 2024-07-22T18:07:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/contemporary-management-of-mesothelioma/ 2024-07-22T18:12:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/incidental-diagnosis-of-malignant-peritoneal-mesothelioma-during-liver-transplantation-surgery-a-case-report/ 2024-07-22T21:19:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/primary-peritoneal-mesothelioma-affecting-the-greater-omentum-that-mimicked-an-omental-infarction-a-case-report/ 2024-07-22T22:11:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluating-the-anticancer-potential-of-polygonum-multiflorum-root-derived-stilbenes-against-h2452-malignant-pleural-mesothelioma-cells/ 2024-07-29T15:53:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/psychological-interventions-for-mesothelioma-patients-and-their-caregivers-a-systematic-literature-review/ 2024-07-29T16:19:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/leucine-rich-%ce%b12-glycoprotein-1-derived-from-malignant-pleural-mesothelioma-cells-facilitates-macrophage-m2-phenotypes/ 2024-07-29T17:42:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-hyperthermic-intrathoracic-chemotherapy-hithoc-in-thoracic-tumors/ 2024-07-29T20:42:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/quality-of-life-after-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-crs-hipec-cancer-survivors-perspective-through-in-depth-interviews/ 2024-07-29T21:25:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/combined-detection-of-shox2-and-ptger4-methylation-with-serum-marker-cyfra21-1-for-improved-diagnosis-of-malignant-pleural-mesothelioma/ 2024-08-05T14:46:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/update-on-gene-fusions-and-the-emerging-clinicopathological-landscape-of-peritoneal-and-pleural-mesotheliomas-and-other-neoplasms/ 2024-08-05T15:09:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/research-progress-of-malignant-peritoneal-mesothelioma-with-paraneoplastic-syndrome-a-review/ 2024-08-05T15:24:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/major-response-of-a-peritoneal-mesothelioma-to-nivolumab-and-ipilimumab-a-case-report-molecular-analysis-and-review-of-literature/ 2024-08-05T15:50:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-in-the-study-of-natural-killer-cells-for-malignant-peritoneal-mesothelioma-treatment/ 2024-08-12T15:38:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/application-of-the-international-system-for-reporting-serous-fluid-cytopathology-on-pleural-effusion-cytology-with-paired-pleural-biopsy-a-new-insight-and-novel-approach-on-risk-of-malignancy/ 2024-08-12T16:30:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/chemotherapy-increases-cda-expression-and-sensitizes-malignant-pleural-mesothelioma-cells-to-capecitabine-treatment/ 2024-08-12T16:59:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/enhancing-the-immunogenicity-of-wilms-tumor-1-epitope-in-mesothelioma-cells-with-immunoproteasome-inhibitors/ 2024-08-12T17:50:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/patient-characteristics-treatment-patterns-and-survival-outcomes-for-patients-with-malignant-pleural-mesothelioma-in-denmark-between-2011-and-2018-a-nationwide-population-based-cohort-study/ 2024-08-12T19:58:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-first-line-chemotherapeutics-and-validation-of-the-eortc-prognostic-index-in-malignant-pleural-mesothelioma-retrospective-single-centre-experience/ 2024-08-12T21:31:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/peritoneal-dissemination-in-patients-with-recurrence-after-post-pleurectomy-decortication-for-pleural-mesothelioma/ 2024-08-19T16:28:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/outcome-prediction-based-on-18ffdg-pet-ct-in-patients-with-pleural-mesothelioma-treated-with-ipilimumab-and-nivolumab-uv1-telomerase-vaccine/ 2024-08-19T17:26:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-fluid-biomarkers-a-narrative-review/ 2024-08-19T17:37:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/stemness-and-hybrid-epithelial-mesenchymal-profiles-guide-peritoneal-dissemination-of-malignant-mesothelioma-and-pseudomyxoma-peritonei/ 2024-08-19T19:10:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/volatile-organic-compound-analysis-of-malignant-pleural-mesothelioma-chorioallantoic-membrane-xenografts/ 2024-08-26T16:56:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/case-report-atm-a1159t-mutation-in-malignant-peritoneal-mesothelioma-may-be-associated-with-tumor-recurrence/ 2024-08-26T18:41:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/unleashing-precision-a-review-of-targeted-approaches-in-pleural-mesothelioma/ 2024-08-26T19:03:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/isolation-and-whole-genomic-analysis-of-mesophilic-bacterium-pseudoglutamicibacter-cumminsii-in-epithelial-mesothelioma/ 2024-08-26T19:12:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-gut-microbiota-rheostat-forecasts-responsiveness-to-pd-l1-and-vegf-blockade-in-mesothelioma/ 2024-08-26T19:47:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/isolation-and-whole-genomic-analysis-of-mesophilic-bacterium-pseudoglutamicibacter-cumminsii-in-epithelial-mesothelioma-2/ 2024-12-09T21:41:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/stk11-lkb1-immunohistochemistry-is-a-sensitive-and-specific-marker-for-stk11-adnexal-tumours/ 2024-12-10T20:39:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-gut-microbiota-rheostat-forecasts-responsiveness-to-pd-l1-and-vegf-blockade-in-mesothelioma-2/ 2024-12-10T20:53:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-characteristics-and-outcomes-of-patients-with-well-differentiated-papillary-peritoneal-mesothelial-tumors/ 2024-12-10T21:16:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-effect-of-cuproptosis-related-proteins-on-macrophage-polarization-in-mesothelioma-is-revealed-by-scrna-seq/ 2024-12-10T21:33:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-effect-of-cuproptosis-related-proteins-on-macrophage-polarization-in-mesothelioma-is-revealed-by-scrna-seq-2/ 2024-12-16T21:58:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/drug-sensitivity-tumor-cell-clusters-in-malignant-peritoneal-mesothelioma/ 2024-12-16T22:21:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/drug-sensitivity-tumor-cell-clusters-in-malignant-peritoneal-mesothelioma-2/ 2024-12-17T18:29:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunohistochemical-evaluation-of-schlafen-11-slfn11-expression-in-cancer-in-the-search-of-biomarker-informed-treatment-targets-a-study-of-127-entities-represented-by-6658-tumors/ 2024-12-17T18:48:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/perfusion-strategies-for-cytoreductive-surgery-with-heated-intraperitoneal-chemotherapy-for-malignant-peritoneal-mesothelioma/ 2024-12-17T20:15:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-significance-of-the-morphological-appearance-of-peritoneal-lesions-on-imaging-in-patients-with-peritoneal-malignancies-a-report-from-phase-1-of-the-precinct-study/ 2024-12-23T17:51:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/challenging-the-norm-occurrence-of-synchronous-pleural-and-peritoneal-mesothelioma-in-a-female-patient/ 2024-12-23T19:56:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/gfpt2-a-novel-biomarker-in-mesothelioma-for-diagnosis-and-prognosis-and-its-molecular-mechanism-in-malignant-progression/ 2024-12-23T20:07:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/transfer-learning-approach-in-pre-treatment-ct-images-to-predict-therapeutic-response-in-advanced-malignant-pleural-mesothelioma/ 2024-12-23T20:24:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/crispr-mediated-genome-editing-reveals-a-preponderance-of-non-oncogene-addictions-as-targetable-vulnerabilities-in-pleural-mesothelioma/ 2024-12-23T20:33:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/determinants-of-mortality-among-us-patients-diagnosed-with-malignant-pleural-mesothelioma-over-the-past-decade/ 2025-01-03T17:10:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-t-cell-ratios-on-survival-in-pleural-mesothelioma-insights-from-tumor-microenvironment-analysis/ 2025-01-03T17:18:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-i-clinical-trial-on-pleural-mesothelioma-using-neoadjuvant-local-administration-of-paclitaxel-loaded-mesenchymal-stromal-cells-paclimes-trial-study-rationale-and-design/ 2025-01-03T17:32:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-for-treatment-of-pleural-mesothelioma-current-and-emerging-therapeutic-strategies/ 2025-01-03T19:43:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/gender-and-age-based-characterization-and-comparison-of-the-murine-primary-peritoneal-mesothelial-cell-proteome/ 2025-01-03T21:31:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/fractionated-low-dose-radiotherapy-primes-the-tumor-microenvironment-for-immunotherapy-in-a-murine-mesothelioma-model/ 2025-01-06T18:29:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-endothelial-venules-in-the-pleura-meca-79-expression-in-mesothelioma-pleural-metastasis-and-pleuritis/ 2025-01-06T20:52:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/systemic-therapy-options-for-peritoneal-mesothelioma/ 2025-01-06T20:58:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-of-first-line-nivolumab-plus-ipilimumab-in-unresectable-pleural-mesothelioma-a-multicenter-real-world-study-immunomeso-latam/ 2025-01-06T21:26:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/stem-like-exhausted-cd8-t-cells-in-pleural-effusions-predict-improved-survival-in-non-small-cell-lung-cancer-nsclc-and-mesothelioma/ 2025-01-06T21:41:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/double-immune-checkpoint-inhibitor-therapy-for-unresectable-pleural-mesothelioma-rarely-induces-hyperprogressive-disease-a-case-report/ 2025-01-13T20:30:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/activation-of-platelet-derived-growth-factor-receptors-regulate-connective-tissue-growth-factor-protein-levels-via-the-akt-pathway-in-malignant-mesothelioma-cells/ 2025-01-13T21:02:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/characteristics-of-long-term-survivors-with-malignant-pleural-mesothelioma/ 2025-01-13T21:21:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/antigen-targeting-and-anti-tumor-activity-of-a-novel-anti-cd146-212pb-internalizing-alpha-radioimmunoconjugate-against-malignant-peritoneal-mesothelioma/ 2025-01-14T22:06:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-impact-of-charcot-leyden-crystal-protein-on-mesothelioma-chemotherapy-targeting-eosinophils-for-enhanced-chemosensitivity/ 2025-01-14T22:22:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-survival-prediction-based-on-a-six-gene-transcriptomic-signature/ 2025-01-20T19:31:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/antigen-targeting-and-anti-tumor-activity-of-a-novel-anti-cd146-212pb-internalizing-alpha-radioimmunoconjugate-against-malignant-peritoneal-mesothelioma-2/ 2025-01-20T19:55:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-impact-of-charcot-leyden-crystal-protein-on-mesothelioma-chemotherapy-targeting-eosinophils-for-enhanced-chemosensitivity-2/ 2025-01-20T20:06:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/effects-of-patient-pleural-effusion-fluids-on-the-bbsome-components-expression-of-human-benign-mesothelial-cells/ 2025-01-20T22:32:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/biomarkers-to-predict-the-benefits-of-immune%e2%80%91checkpoint-blockade%e2%80%91based-therapy-in-patients-with-malignant-peritoneal-mesothelioma-review/ 2025-01-20T23:07:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/metastatic-mesothelioma-of-the-tunica-vaginalis-presenting-as-scrotal-and-abdominal-nodules-a-case-report-and-review-of-the-literature/ 2025-01-27T19:08:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/biomarkers-to-predict-the-benefits-of-immune%e2%80%91checkpoint-blockade%e2%80%91based-therapy-in-patients-with-malignant-peritoneal-mesothelioma-review-2/ 2025-01-27T19:26:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/potential-treatment-approaches-for-malignant-peritoneal-mesothelioma-in-vivo-and-in-vitro-experimental-study-of-natural-killer-cell-immunotherapy/ 2025-01-27T19:32:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/biomarkers-to-predict-the-benefits-of-immune%e2%80%91checkpoint-blockade%e2%80%91based-therapy-in-patients-with-malignant-peritoneal-mesothelioma-review-3/ 2025-01-27T21:10:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/real-world-outcomes-for-patients-with-pleural-mesothelioma-a-multisite-retrospective-cohort-study/ 2025-01-27T22:26:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/safety-and-efficacy-of-pd-1-pd-l1-immune-checkpoint-inhibitors-in-patients-with-pre-treated-advanced-stage-malignant-mesothelioma-a-systematic-review-and-meta-analysis/ 2025-02-03T19:16:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/ascites-as-a-rare-manifestation-of-malignant-peritoneal-mesothelioma-a-case-report/ 2025-02-03T19:31:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-factors-of-long-term-survival-and-conditional-survival-analysis-in-mpm-patients-treated-with-crshipec-a-retrospective-study-of-two-centers/ 2025-02-03T19:47:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/case-report-targeted-therapy-of-malignant-pleural-mesothelioma-with-anaplastic-lymphoma-kinase-receptor-tyrosine-kinase-gene-fusion-mutation-by-crizotinib/ 2025-02-03T20:51:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/epithelioid-pleural-mesothelioma-successfully-treated-with-perioperative-immunotherapy-a-case-report/ 2025-02-03T21:16:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/epithelioid-pleural-mesothelioma-successfully-treated-with-perioperative-immunotherapy-a-case-report-2/ 2025-02-10T18:35:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-perspectives-and-novel-preclinical-models-of-malignant-pleural-mesothelioma-a-critical-review/ 2025-02-10T19:02:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-and-safety-of-novel-multiple-chain-dap-car-t-cells-targeting-mesothelin-in-ovarian-cancer-and-mesothelioma-a-single-arm-open-label-and-first-in-human-study/ 2025-02-10T19:09:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/notch-and-ptp4a3-alterations-emerge-as-novel-predictive-biomarkers-and-potential-therapeutic-targets-in-pleural-mesothelioma/ 2025-02-10T19:18:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-impact-of-age-on-the-efficacy-of-radiotherapy-in-pleural-mesothelioma-patients-receiving-trimodality-therapy-a-population-based-study-of-the-seer-database/ 2025-02-10T22:47:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/affinity-tuned-mesothelin-car-t-cells-demonstrate-enhanced-targeting-specificity-and-reduced-off-tumor-toxicity/ 2025-02-17T18:49:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-survival-from-multidisciplinary-treatment-of-primary-malignant-pericardial-mesothelioma-a-case-report/ 2025-02-17T18:57:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/reconstruction-of-diaphragm-with-cadaveric-fascia-lata-during-extended-surgery-for-pleural-mesothelioma-a-single-center-experience/ 2025-02-17T19:02:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-psychological-impact-of-living-with-peritoneal-mesothelioma-an-interpretative-phenomenological-analysis/ 2025-02-17T19:20:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/paradoxical-improvement-in-malignant-pleural-mesothelioma-outcomes-following-delayed-treatment-initiation/ 2025-02-17T19:26:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgery-for-pleural-mesothelioma-in-multimodality-setting-comparison-between-surgical-techniques-in-a-high-volume-centre/ 2025-02-24T18:11:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-surgical-treatment-and-systemic-chemotherapy-in-patients-with-non-epithelioid-malignant-pleural-mesothelioma/ 2025-02-24T18:18:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-and-in-vitro-evaluation-of-doxorubicin-loaded-methacrylate-gelatin-gelma-acrylamide-hydrogels-for-the-treatment-of-malignant-pleural-mesothelioma/ 2025-02-24T18:26:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/diffuse-pleural-mesothelioma-a-challenge-in-early-diagnosis/ 2025-02-24T18:31:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-and-in-vitro-evaluation-of-doxorubicin-loaded-methacrylate-gelatin-gelma-acrylamide-hydrogels-for-the-treatment-of-malignant-pleural-mesothelioma-2/ 2025-02-24T18:46:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-prevalence-and-prognostic-significance-of-sarcopenia-and-adipopenia-in-pleural-mesothelioma/ 2025-03-03T17:33:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/role-of-immunocytochemistry-in-the-cytological-diagnosis-of-mesothelioma/ 2025-03-03T18:17:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/serum-cytokines-as-a-biomarker-for-immune-checkpoint-inhibitor-toxicity-in-patients-with-pleural-mesothelioma/ 2025-03-03T18:35:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/palliative-and-end-of-life-care-for-patients-with-pleural-mesothelioma-a-cohort-study/ 2025-03-03T18:56:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/tead-independent-cell-growth-of-hippo-inactive-mesothelioma-cells-unveiling-resistance-to-tead-inhibitor-k-975-through-myc-signaling-activation/ 2025-03-03T19:01:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/human-exposure-to-asbestos-in-central-asian-countries-and-health-effects-a-narrative-review/ 2025-03-10T16:06:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/american-association-of-bronchology-and-interventional-pulmonology-essential-knowledge-in-interventional-pulmonology-series-selected-topics-in-malignant-pleural-disease/ 2025-03-10T16:46:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/ecteinascidin-synthetic-analogues-a-new-class-of-selective-inhibitors-of-transcription-exerting-immunogenic-cell-death-in-refractory-malignant-pleural-mesothelioma/ 2025-03-10T16:53:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/case-report-radiological-features-of-a-case-of-desmoplastic-malignant-mesothelioma-of-peritoneum/ 2025-03-10T19:33:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgical-indications-for-pleurectomy-decortication-in-pleural-mesothelioma-based-on-the-newly-revised-9th-edition-of-the-tumour-node-metastasis-classification/ 2025-03-10T19:42:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-effect-of-systemic-inflammation-and-clinicopathologic-features-on-survival-in-malignant-pleural-mesothelioma-a-multicenter-analysis/ 2025-03-17T19:24:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/analysis-of-tert-mrna-levels-and-clinicopathological-features-in-patients-with-peritoneal-mesothelioma/ 2025-03-17T20:28:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-differentiation-between-two-rare-entities-metastatic-peritoneal-mesothelioma-with-duodenal-involvement-and-duodenal-synovial-sarcoma-a-case-report/ 2025-03-17T21:23:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/overcoming-resistance-to-arginine-deprivation-therapy-using-gc7-in-pleural-mesothelioma/ 2025-03-17T21:44:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/analysis-of-pleiotropic-effects-of-nivolumab-in-patients-with-relapsed-pleural-mesothelioma-a-single-center-retrospective-study/ 2025-03-17T22:02:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/combining-a-wt1-vaccine-galinpepimut-s-with-checkpoint-inhibition-nivolumab-in-patients-with-wt1-expressing-diffuse-pleural-mesothelioma-a-phase-1-study/ 2025-03-24T17:39:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-randomised-phase-iii-study-of-bevacizumab-and-carboplatin-pemetrexed-chemotherapy-with-or-without-atezolizumab-as-first-line-treatment-for-advanced-pleural-mesothelioma-results-of-the-etop-13-18-be/ 2025-03-24T17:51:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/recurrence-patterns-and-management-after-pleurectomy-decortication-for-pleural-mesothelioma/ 2025-03-24T18:47:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/follow-up-after-first-line-nivolumab-plus-ipilimumab-in-patients-with-diffuse-pleural-mesothelioma-a-real-world-dutch-cohort-study-flora/ 2025-03-24T18:58:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/preclinical-efficacy-and-proteomic-prediction-of-molecular-targets-for-s-cal14-1b-and-s-cal14-2b-conotoxins-with-antitumor-capacity-in-xenografts-of-malignant-pleural-mesothelioma/ 2025-03-24T21:27:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-effect-of-systemic-inflammation-and-clinicopathologic-features-on-survival-in-malignant-pleural-mesothelioma-a-multicenter-analysis-2/ 2025-03-31T17:24:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoreductive-surgery-in-diffuse-pleural-mesothelioma-what-have-we-learnt-from-mars2-eortc-l1205-and-other-recent-studies/ 2025-03-31T17:42:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-of-cryobiopsy-during-medical-thoracoscopy-for-diagnosing-malignant-pleural-mesothelioma/ 2025-03-31T17:53:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/radiotherapy-of-the-pleural-cavity-in-patients-with-primary-and-secondary-malignancies-of-the-pleura/ 2025-03-31T18:04:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-status-of-staging-and-restaging-malignant-pleural-mesothelioma/ 2025-03-31T18:10:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumor-treating-fields-enhance-chemotherapy-efficacy-by-increasing-cellular-drug-uptake-and-retention-in-mesothelioma-cells/ 2025-04-07T17:16:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-meta-analysis-of-first-line-treatments-for-unresectable-pleural-mesothelioma-indirect-comparisons-from-reconstructed-individual-patient-data-of-six-randomized-controlled-trials/ 2025-04-07T17:28:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-challenges-in-the-pathological-approach-to-pleural-mesothelioma/ 2025-04-07T17:34:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-stratification-of-epithelioid-pleural-mesothelioma-based-on-the-hippo-teads-network/ 2025-04-07T17:41:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-importance-of-the-neutrophil-to-lymphocyte-ratio-in-malignant-peritoneal-mesothelioma-patients-receiving-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy/ 2025-04-07T20:52:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/potential-utility-of-mirnas-derived-from-pleural-fluid-extracellular-vesicles-to-differentiate-between-benign-and-malignant-pleural-effusions/ 2025-04-14T16:55:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/dna-methylation-status-classifies-pleural-mesothelioma-cells-according-to-their-immune-profile-implication-for-precision-epigenetic-therapy/ 2025-04-14T19:24:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/cd276-as-a-critical-independent-biomarker-and-immune-checkpoint-inhibitor-target-in-epithelioid-mesothelioma-tcga-study/ 2025-04-14T19:32:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-phenogenomic-landscapes-of-pleural-mesothelioma-tumor-microenvironment-predict-clinical-outcomes/ 2025-04-14T19:39:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/mirna-503-inhibition-exerts-anticancer-effects-and-reduces-tumor-growth-in-mesothelioma/ 2025-04-14T19:56:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/telomeres-and-telomerase-in-mesothelioma-pathophysiology-biomarkers-and-emerging-therapeutic-strategies-review/ 2025-04-21T16:01:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/leveraging-immunogenic-cell-death-to-enhance-the-immune-response-against-malignant-pleural-mesothelioma-tumors/ 2025-04-21T16:43:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/fabp5-is-a-key-player-in-metabolic-modulation-and-nf-%ce%bab-dependent-inflammation-driving-pleural-mesothelioma/ 2025-04-21T17:26:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-and-future-perspective-of-pet-ct-in-response-assessment-of-malignant-pleural-mesothelioma/ 2025-04-21T19:06:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-of-ph-adjusted-nmr-methodology-for-quantitation-of-caffeoylquinic-acid-derivatives-and-evaluation-of-their-antimalignant-pleural-mesothelioma-potential/ 2025-04-21T19:15:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/sarcomatoid-pleural-mesothelioma-evaluated-using-diffusion-weighted-whole-body-imaging-with-background-body-signal-suppression/ 2025-04-28T17:06:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-neoadjuvant-and-adjuvant-pleural-intensity-modulated-radiotherapy-in-multimodality-treatment-for-malignant-pleural-mesothelioma/ 2025-04-28T17:35:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-significance-of-bone-metastases-in-pleural-mesothelioma/ 2025-04-28T17:47:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/potential-advantage-of-magnetic-resonance-imaging-in-detecting-thoracic-wall-infiltration-in-pleural-mesothelioma-a-retrospective-single-center-analysis/ 2025-04-28T17:56:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-cell-heterogeneity-identified-by-single-cell-rna-sequencing/ 2025-04-28T18:46:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/potent-and-durable-control-of-mesothelin-expressing-tumors-by-a-novel-t-cell-secreted-bi-specific-engager/ 2025-05-05T16:30:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-value-of-chest-ct-volumetric-analysis-in-patients-with-malignant-pleural-mesothelioma/ 2025-05-05T17:12:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-and-validation-of-a-prognostic-nomogram-for-patients-with-malignant-peritoneal-mesothelioma/ 2025-05-05T17:25:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/pd-l1-pfernas-as-blood-based-predictors-of-treatment-response-of-unresectable-malignant-pleural-mesothelioma-patients-administered-durvalumab-with-cisplatin-and-pemetrexed-as-first-line-therapy/ 2025-05-05T17:41:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-soluble-csf-1r-dimeric-mutein-with-enhanced-trapping-of-both-csf-1-and-il-34-reduces-suppressive-tumor-associated-macrophages-in-pleural-mesothelioma/ 2025-05-05T19:37:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-soluble-csf-1r-dimeric-mutein-with-enhanced-trapping-of-both-csf-1-and-il-34-reduces-suppressive-tumor-associated-macrophages-in-pleural-mesothelioma-2/ 2025-05-12T17:44:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-woman-with-a-pleural-mesothelioma-and-an-inherited-atm-mutation-a-case-report/ 2025-05-12T17:54:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/dna-methylation-regulated-hla-c-expression-modulates-immune-responses-and-metabolic-alterations-to-influence-prognosis-in-mesothelioma/ 2025-05-12T18:01:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/ex-vivo-drug-sensitivity-testing-to-predict-clinical-response-in-non-small-cell-lung-cancer-and-pleural-mesothelioma-a-systematic-review-and-narrative-synthesis/ 2025-05-12T18:13:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-utility-of-pleuroscopic-guided-pleural-biopsy-versus-pleural-fluid-cell-block-in-the-diagnosis-of-malignant-pleural-effusion/ 2025-05-12T18:22:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/utility-and-limitations-of-merlin-immunohistochemistry-for-mesothelioma-diagnosis-in-tissue-sections-and-cell-blocks/ 2025-05-19T16:34:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/genome-wide-crispr-screen-identifies-bub1-kinase-as-a-druggable-vulnerability-in-malignant-pleural-mesothelioma/ 2025-05-19T16:53:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/hyperthermic-intrathoracic-chemotherapy-in-patients-with-malignant-pleural-mesothelioma-after-cytoreductive-surgical-procedures-a-systematic-review/ 2025-05-19T17:05:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/ad-sge-dkk3-gene-therapy-overcomes-resistance-to-immune-checkpoint-blockade-in-pleural-mesothelioma/ 2025-05-19T17:49:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/multicystic-peritoneal-mesothelioma-with-floret-like-multinucleated-giant-cells-a-case-report/ 2025-05-27T16:56:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/incidence-and-outcomes-of-brain-metastasis-in-pleural-mesothelioma-in-the-era-of-immunotherapy/ 2025-05-27T18:50:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/radical-hemithorax-radiotherapy-induces-an-increase-in-circulating-pd-1-t-lymphocytes-and-in-the-soluble-levels-of-pd-l1-in-malignant-pleural-mesothelioma-patients-a-possible-synergy-with-pd-1-pd-l1/ 2025-05-27T17:26:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoplasmic-hur-expression-enhances-chemoresistance-in-pleural-mesothelioma-through-increased-expression-of-calb2-promotion-of-the-e2f-pathway-and-suppression-of-the-p53-pathway/ 2025-05-27T18:58:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-and-safety-of-bintrafusp-alfa-evaluated-in-a-phase-ii-single-arm-clinical-trial-in-previously-treated-advanced-pleural-mesothelioma/ 2025-05-27T21:16:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-in-mesothelioma-systematic-review-and-meta-analysis-of-immunotherapy-impact-on-os-and-its-correlation-with-pfs-and-orr/ 2025-06-02T14:49:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumor-treating-fields-ttfields-therapy-in-unresectable-pleural-mesothelioma-overview-of-efficacy-safety-and-future-outlook/ 2025-06-02T15:48:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-of-immunotherapy-versus-chemotherapy-in-advanced-pleural-mesothelioma-a-turkish-oncology-group-tog-study/ 2025-06-02T16:15:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-mesothelioma-systemic-inflammation-score-is-independently-associated-with-overall-survival-and-predicts-benefit-of-multimodality-treatment-in-pleural-mesothelioma/ 2025-06-02T17:21:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/bidirectional-mendelian-randomization-and-potential-mechanistic-insights-into-the-causal-relationship-between-gut-microbiota-and-malignant-mesothelioma/ 2025-06-02T17:49:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-rare-case-of-sarcomatoid-type-localized-pleural-mesothelioma-derived-from-visceral-pleura/ 2025-06-09T16:50:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelial-and-immune-cells-interplay-in-the-tumor-microenvironment/ 2025-06-09T17:45:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/combined-quetiapine-and-radiation-therapy-approach-to-treat-mesothelioma-initiating-cells-and-increase-survival-in-a-mouse-model-of-mesothelioma/ 2025-06-09T17:54:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/significance-of-18f-fluorodeoxyglucose-pet-computed-tomography-in-the-initial-staging-of-malignant-peritoneal-mesothelioma/ 2025-06-09T18:04:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/oncological-outcomes-of-radical-surgery-with-and-without-induction-and-adjuvant-chemotherapy-in-mesothelioma-patients-8-year-experience-in-a-single-center/ 2025-06-09T18:14:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/enhanced-detection-of-recurrent-diffuse-malignant-peritoneal-mesothelioma-using-68-ga-fapi-pet-ct-compared-to-18-f-fdg-pet-ct-a-case-report/ 2025-06-16T18:18:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/pd-1-blockade-mitigates-surgery-induced-immunosuppression-and-increases-the-efficacy-of-photodynamic-therapy-for-pleural-mesothelioma/ 2025-06-16T17:32:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/unraveling-bold-100-synergistic-potential-in-pleural-mesothelioma-treatment-an-in-vitro-study/ 2025-06-16T18:04:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/predicting-mesothelioma-using-artificial-intelligence-a-scoping-review-of-common-models-and-applications/ 2025-06-16T18:25:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-mechanisms-of-tumor-progression-and-novel-therapeutic-and-diagnostic-strategies-in-mesothelioma/ 2025-06-16T18:31:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-mutations-and-pleural-mesothelioma-genetic-insights-clinical-implications-and-therapeutic-perspectives/ 2025-06-23T16:53:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-significance-of-tumor-infiltrating-lymphocytes-in-malignant-peritoneal-mesothelioma-a-single-center-study-of-143-cases/ 2025-06-23T17:01:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/deoxypodophyllotoxin-inhibited-the-growth-of-malignant-pleural-mesothelioma-by-inducing-necroptosis-and-mitotic-catastrophe/ 2025-06-23T17:10:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/breaking-through-immunotherapy-innovations-in-pleural-mesothelioma/ 2025-06-23T17:15:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-value-of-cyclin-d1-immunohistochemistry-in-differentiating-malignant-mesothelioma-from-reactive-mesothelial-proliferation/ 2025-06-23T17:28:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-bibliometric-analysis-of-malignant-pleural-mesothelioma-from-2010-to-2023/ 2025-06-30T16:42:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/from-asbestos-exposure-to-carcinogenesis-transcriptomic-signatures-in-malignant-pleural-mesothelioma/ 2025-06-30T16:51:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/epithelial-mesenchymal-plasticity-in-the-d-meso-sonobe-mesothelioma-cell-line-a-putative-model-of-epithelial-mesenchymal-transition-in-mesothelioma/ 2025-06-30T17:04:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/keynote-a17-first-line-pembrolizumab-plus-cisplatin-pemetrexed-in-japanese-participants-with-advanced-pleural-mesothelioma/ 2025-06-30T17:50:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-four-mirna-signature-as-a-potential-biomarker-of-malignant-mesothelioma-patients-from-hand-spinning-asbestos-exposed-area-in-eastern-china/ 2025-06-30T18:05:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/dual-immunotherapy-for-pericardial-mesothelioma-that-developed-after-a-decade-long-idiopathic-pericarditis-a-case-report/ 2025-07-07T16:44:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/sarcomatoid-mesothelioma-vs-myogenic-sarcoma-a-strong-case-for-diagnostic-electron-microscopy-a-case-report/ 2025-07-07T16:59:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/national-guidelines-for-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-hipec-in-peritoneal-malignancies-a-worldwide-systematic-review-and-recommendations-of-strength-analysis/ 2025-07-07T17:06:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/cisplatin-potentiates-pd-l1-expression-more-robustly-than-pemetrexed-in-malignant-pleural-mesothelioma-temporal-dynamics-revealed-by-cellular-and-xenograft-analyses/ 2025-07-07T17:16:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/co-targeting-of-vegfr2-and-pd-l1-promotes-survival-and-vasculature-normalization-in-pleural-mesothelioma/ 2025-07-07T17:25:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-with-a-novel-bap1-germline-frameshift-mutation-treated-with-dual-immune-checkpoint-inhibitors-a-case-report/ 2025-07-14T14:36:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-of-duodenal-metastasis-from-malignant-pleural-mesothelioma-diagnosed-by-gastrointestinal-endoscopy-following-progressive-anemia-during-salvage-chemotherapy/ 2025-07-14T15:21:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/immune-related-gene-risk-model-establishment-and-role-of-key-gene-fuca1-in-malignant-pleural-mesothelioma/ 2025-07-14T16:54:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/exploration-of-the-anticancer-properties-of-caffeic-acid-in-malignant-mesothelioma-cells/ 2025-07-14T17:37:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/low-dose-photodynamic-therapy-promotes-vascular-e-selectin-expression-in-chest-malignancies-improving-immune-infiltration-and-tumor-control/ 2025-07-14T18:00:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/volatile-organic-compounds-in-exhaled-human-breath-for-the-diagnosis-of-malignant-pleural-mesothelioma-a-meta-analysis/ 2025-07-21T17:06:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-insights-into-pleural-mesothelioma-unveiling-pathogenic-mechanisms-and-therapeutic-opportunities/ 2025-07-21T17:30:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/characteristics-of-long-term-survivors-with-peritoneal-mesothelioma-insights-from-the-national-cancer-database/ 2025-07-21T17:44:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-a-novel-prognostic-gene-signature-in-pleural-mesothelioma-a-study-based-on-the-cancer-genome-atlas-database-and-experimental-validation/ 2025-07-21T17:53:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-heart-development-protein-with-egf-like-domains-1-heg1-decorated-with-low-sulfated-keratan-sulfate-in-human-malignant-pleural-mesothelioma/ 2025-07-21T18:02:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-a-novel-prognostic-gene-signature-in-pleural-mesothelioma-a-study-based-on-the-cancer-genome-atlas-database-and-experimental-validation-2/ 2025-07-28T15:33:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-and-future-applications-of-artificial-intelligence-in-lung-cancer-and-mesothelioma/ 2025-07-28T16:02:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-multimodal-surgical-resection-and-personalized-targeted-therapy-on-survival-outcomes-in-early-stage-malignant-pleural-mesothelioma-a-meta-analysis/ 2025-07-28T16:16:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/fibulin-3-in-plasma-and-pleural-effusion-as-a-biomarker-of-mesothelioma/ 2025-07-28T16:26:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/pbk-expression-promotes-the-aggressive-phenotypes-of-mesothelioma/ 2025-07-28T16:47:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/8c7-a-fully-human-anti-ptgfrn-monoclonal-antibody-drug-conjugate-inhibiting-tumour-growth-of-mesothelioma-and-paediatric-medulloblastoma-cell-lines/ 2025-08-04T13:44:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/retreatment-with-nivolumab-and-ipilimumab-in-pleural-mesothelioma-following-disease-progression-after-a-durable-response-case-series/ 2025-08-04T16:38:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/loss-of-mtap-expression-is-not-an-accurate-surrogate-for-cdkn2a-homozygous-deletions-in-peritoneal-mesothelioma/ 2025-08-04T18:07:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/hmgb1-as-a-key-mediator-in-malignant-mesothelioma-and-a-potential-target-for-asbestos-related-cancer-therapy/ 2025-08-04T18:24:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/immune-composition-and-immunotherapy-outcomes-of-mesothelioma-with-bap1-cdkn2a-mtap-and-nf2-alterations/ 2025-08-04T18:31:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-and-pathologic-phenotyping-of-mesotheliomas-developing-in-carriers-of-germline-bap1-mutations/ 2025-08-11T17:33:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-side-effects-after-volumetric-modulated-arc-therapy-to-the-pleura-in-patients-with-malignant-pleural-mesothelioma/ 2025-08-11T18:09:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/prolonged-survival-in-mesothelioma-patients-without-surgical-resection-a-national-cancer-database-analysis/ 2025-08-11T18:21:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-giant-peritoneal-mesothelioma-extending-to-the-pelvic-floor-a-case-report-and-review-of-the-literature/ 2025-08-11T18:28:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-value-of-the-halp-score-in-metastatic-mesothelioma-a-retrospective-study/ 2025-08-11T18:35:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/medical-thoracoscopy-in-malignant-pleural-effusion/ 2025-08-18T13:35:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-evolving-role-of-chemotherapy-in-the-management-of-pleural-malignancies-current-evidence-and-future-directions/ 2025-08-18T13:47:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-road-to-identifying-peritoneal-mesothelioma-an-elusive-diagnosis/ 2025-08-18T17:14:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/microrna-497-5p-based-screening-identifies-a-novel-synthetic-lethal-type-interaction-via-pkmyt1-and-wee1-in-pleural-mesothelioma/ 2025-08-18T17:32:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/serum-mesothelin-as-a-response-biomarker-in-pleural-mesothelioma/ 2025-08-18T17:45:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/serum-mesothelin-as-a-response-biomarker-in-pleural-mesothelioma-2/ 2025-08-25T17:58:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/neoadjuvant-immunotherapy-in-a-solitary-isolated-peritoneal-mesothelioma-involving-the-abdominal-wall-a-case-report/ 2025-08-25T18:08:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/enhanced-efficacy-of-immune-checkpoint-inhibitors-with-ok-432-in-malignant-pleural-mesothelioma-a-case-report/ 2025-08-25T18:15:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/towards-a-new-approach-in-pleural-mesothelioma-perioperative-immunotherapy-and-its-implications/ 2025-08-25T18:22:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/effectiveness-of-surgical-treatment-on-survival-of-patients-with-malignant-pleural-mesothelioma/ 2025-08-25T18:29:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/pipeline-to-evaluate-yap-tead-inhibitors-indicates-tead-inhibition-represses-nf2-mutant-mesothelioma/ 2025-09-02T14:39:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/prospective-analysis-of-mesotheliomas-in-subjects-with-bap1-cancer-syndrome-clinical-characteristics-and-epigenetic-correlates-of-disease/ 2025-09-02T15:01:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/single-cell-rna-sequencing-as-a-potential-approach-for-studying-intratumor-heterogeneity-in-pleural-mesothelioma/ 2025-09-02T15:13:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/first-line-nivolumab-plus-ipilimumab-in-pleural-mesothelioma-efficacy-and-safety-data-from-the-real-world-mesonet-study/ 2025-09-02T16:52:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-ldhb-triggers-dna-damage-and-increases-cisplatin-sensitivity-in-pleural-mesothelioma/ 2025-09-08T17:38:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-ldhb-triggers-dna-damage-and-increases-cisplatin-sensitivity-in-pleural-mesothelioma-2/ 2025-09-08T17:50:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-promising-prognostic-indicator-for-pleural-mesothelioma-pan-immuno-inflammation-value/ 2025-09-08T18:01:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/co-targeting-bcl-xl-with-mcl-1-induces-lethal-mitochondrial-dysfunction-in-diffuse-mesothelioma/ 2025-09-08T18:14:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-expression-of-glycosaminoglycans-modifies-the-plasticity-of-biphasic-mesothelioma-in-favor-of-tumor-progression/ 2025-09-08T18:21:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/pemetrexed-plus-platinum-as-second-line-treatment-for-patients-with-pleural-mesothelioma-treated-with-nivolumab-plus-ipilimumab/ 2025-09-15T16:03:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-immunoinflammatory-and-transcriptomic-profiles-in-patients-with-pleural-mesothelioma-undergoing-immunotherapy/ 2025-09-15T16:38:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/partial-response-to-nivolumab-and-ipilimumab-in-a-patient-with-malignant-pleural-mesothelioma-and-pre-existing-myasthenia-gravis-without-severe-flares-or-immune-related-adverse-events-a-case-report/ 2025-09-15T17:58:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/diffuse-intrapulmonary-malignant-mesothelioma-dimm-mimicking-interstitial-lung-disease-ultrastructural-analysis-and-the-potential-role-of-the-hedgehog-signaling-pathway/ 2025-09-15T18:09:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-cembrane-diterpenoids-from-sinularia-sp-that-reduce-the-viability-of-diffuse-pleural-mesothelioma-cell-lines/ 2025-09-15T18:16:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/multi-omics-integration-reveals-cytl1-and-h6pd-as-key-regulators-of-tumor-metabolism-in-mesothelioma/ 2025-09-22T16:38:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-cembrane-diterpenoids-from-sinularia-sp-that-reduce-the-viability-of-diffuse-pleural-mesothelioma-cell-lines-2/ 2025-09-22T17:14:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/cdkn2a-deletion-is-associated-with-immune-desertification-in-diffuse-pleural-mesothelioma/ 2025-09-22T17:29:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/successful-response-to-first-line-carboplatin-pemetrexed-and-bevacizumab-for-peritoneal-mesothelioma-two-case-reports/ 2025-09-22T17:37:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-of-postoperative-immunotherapy-on-mpm-patients-after-crs-hipec-a-single-center-retrospective-study-based-on-propensity-score-matching/ 2025-09-22T17:47:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-sox6-immunohistochemical-expression-as-a-diagnostic-marker-in-the-distinction-of-epithelioid-mesothelioma-from-lung-carcinomas/ 2025-09-30T16:23:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-yb-1-phosphorylation-enhances-cisplatin-activity-and-disrupts-cell-division-in-pleural-mesothelioma/ 2025-09-30T19:06:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/co-targeting-bcl-xl-with-mcl-1-induces-lethal-mitochondrial-dysfunction-in-diffuse-mesothelioma-2/ 2025-09-30T19:18:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-mesothelioma-pathogenesis-diagnosis-treatment-prognosis-and-survival/ 2025-09-30T19:23:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/mir-193b-3p-and-mir-132-3p-as-prognostic-biomarkers-of-survival-in-pleural-mesothelioma-patients-treated-with-first-line-bevacizumab-plus-pemetrexed-platinum-chemotherapy-in-the-ifct-0701-maps-phase-3/ 2025-09-30T19:32:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/perioperative-nivolumab-or-nivolumab-plus-ipilimumab-in-resectable-diffuse-pleural-mesothelioma-a-phase-2-trial-and-ctdna-analyses/ 2025-10-07T15:31:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/combining-chemotherapeutic-agents-targeted-therapies-vaccines-and-natural-bioactive-compounds-for-mesothelioma-advances-and-perspectives/ 2025-10-07T15:57:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleurectomy-decortication-versus-extrapleural-pneumonectomy-in-pleural-mesothelioma-a-systematic-review-and-meta-analysis-of-survival-mortality-and-surgical-trends/ 2025-10-07T16:53:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-local-seeding-in-procedure-tracts-of-pleural-mesothelioma-incidence-and-novel-risk-factors-in-308-patients/ 2025-10-07T19:10:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/inclusion-of-anti-vascular-therapy-as-a-promising-option-for-later-line-treatment-of-malignant-pleural-mesothelioma-a-retrospective-study/ 2025-10-07T19:37:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/genetic-variability-of-hif1a-and-response-to-treatment-with-cisplatin-in-combination-with-pemetrexed-or-gemcitabine-in-patients-with-malignant-mesothelioma/ 2025-10-13T15:54:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/radiologists-guide-to-the-ninth-edition-tnm-staging-system-for-quantitative-and-qualitative-assessment-of-pleural-mesothelioma/ 2025-10-13T18:18:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-and-safety-of-pd-1-pd-l1-and-ctla-4-immune-checkpoint-inhibitors-in-the-treatment-of-diffuse-pleural-mesothelioma-a-systematic-review-and-meta-analysis/ 2025-10-13T19:37:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/genetic-variability-of-hif1a-and-response-to-treatment-with-cisplatin-in-combination-with-pemetrexed-or-gemcitabine-in-patients-with-malignant-mesothelioma-2/ 2025-10-13T19:43:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/pharmacogenomic-characterization-of-a-large-cohort-of-patient-derived-cell-lines-identifies-therapeutic-strategies-for-pleural-mesothelioma/ 2025-10-13T19:56:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-survival-of-nonoccupational-pleural-mesothelioma-a-case-report-and-review-of-the-literature/ 2025-10-22T14:21:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/fl496-an-fl118-derived-small-molecule-induces-growth-inhibition-senescence-and-apoptosis-of-malignant-pleural-mesothelioma-mpm-cells-and-exhibits-anti-mpm-tumor-efficacy-strikingly-superior-to/ 2025-10-22T14:32:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnosis-of-mesothelioma-using-image-segmentation-and-class-based-deep-feature-transformations/ 2025-10-22T14:38:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/external-validation-of-pathological-t-adjustments-in-the-ninth-edition-of-the-pleural-mesothelioma-tumor-node-metastasis-classification/ 2025-10-27T14:33:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/manganese-doped-nanotheranostic-system-for-mri-guided-photothermal-therapy-of-malignant-pleural-mesothelioma-in-vivo-study/ 2025-10-27T14:52:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-non-coding-rnas-in-pleural-mesothelioma/ 2025-10-27T15:24:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/discovery-of-actionable-drug-targets-to-enhance-t-cell-infiltration-and-immune-checkpoint-blockade-efficacy-in-pleural-mesothelioma/ 2025-10-27T15:38:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/apical-malignant-pleural-mesothelioma-presenting-as-horners-syndrome-a-case-report/ 2025-10-27T15:46:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-rare-clinical-presentation-of-malignant-pleural-mesothelioma-with-central-nervous-system-metastases-a-case-report/ 2025-11-03T15:23:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/resveratrol-affects-cell-activities-induces-apoptosis-and-regulates-ampk-signaling-pathway-in-pleural-mesothelioma-cells/ 2025-11-03T15:33:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/fl496-an-fl118-derived-small-molecule-induces-growth-inhibition-senescence-and-apoptosis-of-malignant-pleural-mesothelioma-mpm-cells-and-exhibits-anti-mpm-tumor-efficacy-strikingly-superior-to-2/ 2025-11-03T16:02:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/fl496-an-fl118-derived-small-molecule-induces-growth-inhibition-senescence-and-apoptosis-of-malignant-pleural-mesothelioma-mpm-cells-and-exhibits-anti-mpm-tumor-efficacy-strikingly-superior-to-3/ 2025-11-03T16:23:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-the-efficacy-of-first-line-pemetrexed-platinum-and-gemcitabine-platinum-regimens-in-malignant-peritoneal-mesothelioma/ 2025-11-03T16:38:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-the-efficacy-of-first-line-pemetrexed-platinum-and-gemcitabine-platinum-regimens-in-malignant-peritoneal-mesothelioma-2/ 2025-11-18T15:40:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/pd-l1-expression-as-a-prognostic-factor-for-postoperative-outcomes-in-pleural-mesothelioma/ 2025-11-18T15:50:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/anti-pd-1-nanobody-armored-msln-car-t-therapy-for-malignant-mesothelioma-preclinical-and-clinical-studies/ 2025-11-18T15:58:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/narciclasine-as-a-novel-treatment-for-lung-cancer-and-malignant-pleural-mesothelioma-insights-from-3d-tumor-spheroid-models/ 2025-11-18T16:12:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/dual-hdac-and-pi3k-inhibitor-cudc-907-inhibits-growth-of-pleural-mesothelioma-the-impact-of-cisplatin-sensitivity-and-myc-expression/ 2025-11-18T16:26:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/use-of-patient-derived-organoids-for-pleural-mesothelioma-3d-modelling/ 2025-12-01T15:55:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/narciclasine-as-a-novel-treatment-for-lung-cancer-and-malignant-pleural-mesothelioma-insights-from-3d-tumor-spheroid-models-2/ 2025-12-01T16:59:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-classification-and-survival-prediction-with-ct-imaging-using-resnet/ 2025-12-01T17:13:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/risk-factors-prognostic-factors-and-nomograms-for-distant-metastasis-in-patients-with-malignant-pleural-mesothelioma-a-population-based-retrospective-study/ 2025-12-01T17:32:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-classification-and-survival-prediction-with-ct-imaging-using-resnet-2/ 2025-12-01T17:48:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/intratumour-anatomical-and-temporal-heterogeneity-in-mesothelioma/ 2025-12-15T17:27:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/dynamic-evolution-of-nk-cells-and-immune-remodeling-mediated-by-crs-hipec-prognostic-mechanisms-and-therapeutic-implications-for-malignant-peritoneal-mesothelioma/ 2025-12-15T17:41:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-of-primary-malignant-peritoneal-mesothelioma/ 2025-12-15T17:49:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/neoadjuvant-systemic-therapy-for-pleural-mesothelioma-patients-a-systematic-review/ 2025-12-15T18:01:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/methylation-biomarkers-can-distinguish-pleural-mesothelioma-from-healthy-pleura-and-other-pleural-pathologies/ 2025-12-15T19:45:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/positron-emission-tomography-computed-tomography-in-risk-factor-negative-young-female-with-malignant-pleural-mesothelioma-a-case-report-and-review-of-literature/ 2026-01-05T18:09:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/comprehensive-analysis-reveals-prognostic-gene-set-that-could-impacts-the-response-to-chemotherapy-and-immunotherapy-outcomes-in-malignant-pleural-mesothelioma/ 2026-01-05T18:24:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/unraveling-peritoneal-mesothelioma-a-case-based-discussion-on-diagnosis-and-management/ 2026-01-05T18:32:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/hyperthermic-intrathoracic-chemotherapy-and-photodynamic-therapy-a-single-institution-experience-for-malignant-pleural-diseases/ 2026-01-05T18:50:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-novel-malignant-mesothelioma-organoids-t-cell-co-culture-platform-for-personalized-immunochemotherapy-testing/ 2026-01-05T19:03:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/pembrolizumab-plus-lenvatinib-as-second-line-treatment-in-patients-with-pleural-mesothelioma-pemmela-cohort-2-of-a-single-arm-phase-2-study/ 2026-01-12T17:27:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/circulating-micrornas-as-biomarkers-for-risk-assessment-and-prognostic-stratification-of-pleural-mesothelioma/ 2026-01-12T17:32:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/multiomic-histologic-and-scrna-seq-profiling-of-pleural-mesothelioma-reveals-negative-prognosis-associated-with-a-novel-uncommitted-molecular-phenotype/ 2026-01-12T17:54:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-uparap-with-an-antibody-drug-conjugate-exhibits-efficacy-against-mesothelioma-and-synergizes-with-cisplatin/ 2026-01-12T18:08:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-usefulness-of-full-thickness-biopsy-during-semi-rigid-pleuroscopy-for-differentiating-between-malignant-pleural-mesothelioma-and-non-specific-pleurisy/ 2026-01-12T18:22:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/nintedanib-as-switch-maintenance-treatment-in-malignant-pleural-mesothelioma-nemo-a-double-blind-randomized-phase-ii-trial-eortc-08112-lcg/ 2026-01-19T16:38:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-contrast-pharmacokinetics-a-feasibility-trial-of-the-use-of-pharmacokinetic-analysis-in-small-volume-pleural-malignancy/ 2026-01-19T16:47:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-mesothelioma-diagnosis-for-the-pulmonologist-steps-along-the-way/ 2026-01-19T17:08:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/curcumin-impacts-on-cisplatin-sensitivity-determining-apoptotic-boost-in-mesothelioma/ 2026-01-19T17:19:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/global-patterns-and-trends-in-mesothelioma-incidence-a-retrospective-cross-sectional-study/ 2026-01-19T17:40:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-potential-of-a-novel-immunohistochemical-marker-gfpt2-in-differentiating-mesothelioma-from-its-morphological-mimics/ 2026-01-26T18:40:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/co-occurrence-of-peritoneal-mesothelioma-and-genitourinary-cancers-a-case-series-with-comparative-outcomes/ 2026-01-26T18:46:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-indepso-ispsm-consensus-on-peritoneal-malignancies-diagnosis-and-management-of-peritoneal-mesothelioma/ 2026-01-26T18:53:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/merlin-immunohistochemistry-is-useful-in-the-differential-diagnosis-of-epithelioid-mesothelioma-and-reactive-mesothelial-hyperplasia/ 2026-01-26T18:57:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/near-infrared-spectroscopy-combined-with-machine-learning-for-plasma-based-discriminant-diagnosis-of-malignant-mesothelioma-a-retrospective-study/ 2026-01-26T19:02:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/baicalein-inhibits-proliferation-migration-and-invasion-of-mesothelioma-cells-through-the-p53-foxm1-signaling-axis/ 2026-02-02T17:27:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-radiotherapy-after-pleurectomy-decortication-for-malignant-pleural-mesothelioma-state-of-the-art/ 2026-02-02T17:43:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/near-infrared-spectroscopy-combined-with-machine-learning-for-plasma-based-discriminant-diagnosis-of-malignant-mesothelioma-a-retrospective-study-2/ 2026-02-02T17:54:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytopathologic-features-of-metastatic-malignant-mesothelioma-with-smarcb1-ini-1-deficient-diagnosed-by-ultrasound-guided-fine-needle-aspiration-a-case-report/ 2026-02-02T18:30:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/determinants-of-response-to-immune-checkpoint-blockade-in-pleural-mesothelioma-molecular-immunological-and-clinical-perspectives/ 2026-02-02T18:39:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/epithelioid-mesothelioma-cells-exhibit-increased-ferroptosis-sensitivity-compared-to-non-epithelioid-mesothelioma-cells/ 2026-02-09T18:26:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytopathologic-features-of-metastatic-malignant-mesothelioma-with-smarcb1-ini-1-deficient-diagnosed-by-ultrasound-guided-fine-needle-aspiration-a-case-report-2/ 2026-02-09T18:34:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/integrating-polygenic-and-methylation-risk-scores-for-pleural-mesothelioma-risk-stratification/ 2026-02-09T18:44:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/expanding-the-role-of-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-a-multicenter-study-on-uncommon-peritoneal-malignancies/ 2026-02-09T18:55:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-key-proteins-of-pleural-mesothelioma-using-plumbagin-indole-3-propionic-acid-ester-insights-from-network-pharmacology-molecular-dynamics-simulation-and-machine-learning-based-analysis/ 2026-02-09T19:02:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-loss-in-mesothelioma-molecular-mechanisms-and-clinical-opportunities/ 2026-02-16T20:04:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-loss-in-mesothelioma-molecular-mechanisms-and-clinical-opportunities-2/ 2026-02-16T23:14:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/real-world-outcomes-of-first-line-immunotherapy-and-subsequent-systemic-therapies-in-pleural-mesothelioma-a-multicenter-study-in-china/ 2026-02-16T23:26:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-value-of-fibroblast-activation-protein-directed-pet-imaging-in-pleural-mesothelioma/ 2026-02-16T23:33:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-accuracy-of-video-assisted-thoracic-surgery-pleural-biopsy-in-patients-with-suspected-diffuse-pleural-mesothelioma-a-real-life-study/ 2026-02-16T23:43:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/multi-omic-screening-for-pleural-mesothelioma-in-asbestos-exposed-populations-a-literature-review-and-recommendations/ 2026-02-23T21:02:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/real-world-outcomes-of-first-line-immunotherapy-and-subsequent-systemic-therapies-in-pleural-mesothelioma-a-multicenter-study-in-china-2/ 2026-02-23T21:07:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoreductive-surgery-and-hipec-for-multicystic-peritoneal-mesothelioma-therapeutic-approach-in-a-rare-benign-neoplasm/ 2026-02-23T21:16:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/artificial-intelligence-in-pleural-diseases-current-applications-and-next-steps/ 2026-02-23T21:23:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/nintedanib-as-switch-maintenance-treatment-in-malignant-pleural-mesothelioma-nemo-a-double-blind-randomized-phase-ii-trial-eortc-08112-lcg-2/ 2026-02-23T21:28:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/nintedanib-as-switch-maintenance-treatment-in-malignant-pleural-mesothelioma-nemo-a-double-blind-randomized-phase-ii-trial-eortc-08112-lcg-3/ 2026-03-02T20:50:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-contrast-pharmacokinetics-a-feasibility-trial-of-the-use-of-pharmacokinetic-analysis-in-small-volume-pleural-malignancy-2/ 2026-03-02T20:55:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/risk-factors-of-hematological-toxicity-of-mesothelioma-treatment-a-territory-wide-retrospective-study/ 2026-03-02T20:59:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/cancer-specific-antihuman-podoplanin-antibody-chlpmab-2f-exerts-antitumor-effects-against-pleural-mesothelioma/ 2026-03-02T21:04:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/safety-of-secondary-crs-hipec-in-peritoneal-surface-malignancies-insights-from-a-national-cohort-study/ 2026-03-02T21:10:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparative-analysis-of-malignant-pleural-effusion-and-peripheral-blood-reveals-unique-t-cell-signatures-associated-with-survival-in-mesothelioma-patients/ 2026-03-09T20:01:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-value-and-clinical-significance-of-tumoral-pd-l1-and-stromal-%ce%b1-sma-expression-in-diffuse-pleural-mesothelioma/ 2026-03-09T20:06:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/pd-l1-and-bap1-as-prognostic-biomarkers-in-malignant-pleural-mesothelioma/ 2026-03-09T20:19:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/reactive-oxygen-species-drive-cell-migration-and-pd-l1-expression-via-yb-1-phosphorylation-in-pleural-mesothelioma/ 2026-03-09T20:27:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/time-to-next-procedure-in-patients-with-malignant-pleural-effusion-undergoing-aspiration-derivation-and-initial-validation-of-the-red-score/ 2026-03-09T20:40:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-respiratory-toxicity-and-peritoneal-mesothelioma-induced-by-heat-treated-and-milled-amosite-following-intratracheal-and-intraperitoneal-injection-in-rats/ 2026-03-23T19:52:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/mechanisms-of-chemoresistance-in-malignant-pleural-mesothelioma-the-regulatory-role-of-mirnas/ 2026-03-23T20:09:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/pembrolizumab-plus-platinum-doublet-chemotherapy-with-lenvatinib-in-unresectable-pleural-mesothelioma-as-first-line-treatment-peninsula-a-study-protocol-for-a-single-arm-multi-institutional-phase/ 2026-03-23T20:13:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-patterns-clinical-outcomes-health-care-resource-use-and-costs-in-older-adults-with-malignant-pleural-mesothelioma-in-the-united-states-2007-2020/ 2026-03-23T20:32:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-applications-of-cryobiopsy-in-the-diagnosis-of-thoracic-malignancies-a-comprehensive-review/ 2026-03-23T20:47:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/adverse-renal-outcomes-in-patients-with-mesothelioma-a-territory-wide-real-world-data/ 2026-03-30T18:54:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/neoadjuvant-pressurized-intraperitoneal-aerosol-chemotherapy-for-conversion-to-cytoreductive-surgery-in-unresectable-malignant-peritoneal-mesothelioma-a-report-of-2-cases/ 2026-03-30T19:01:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/disaster-on-mars2-lessons-learned-from-modern-day-outcomes-of-surgery-for-pleural-mesothelioma/ 2026-03-30T19:10:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-specificity-of-heg1-as-mesothelioma-marker-depends-on-the-differential-diagnosis/ 2026-03-30T19:15:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/construction-and-validation-of-a-prognostic-risk-score-model-for-malignant-mesothelioma/ 2026-03-30T19:20:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/feasibility-of-multimodality-treatment-including-pleurectomy-decortication-in-carefully-selected-patients-with-sarcomatoid-mesothelioma/ 2026-04-06T20:13:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/validation-of-chemoresistance-phenotypes-in-pleural-mesothelioma-across-2d-3d-and-in-vivo-models/ 2026-04-06T20:26:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap-1-in-the-diagnosis-of-malignant-pleural-mesothelioma/ 2026-04-06T20:48:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-dosimetric-parameters-in-radiation-pneumonitis-a-functional-approach-in-adjuvant-treatment-of-malignant-pleural-mesothelioma/ 2026-04-06T20:55:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/radiofrequency-ablation-for-recurrent-pleural-mesothelioma/ 2026-04-06T21:03:13+00:00 monthly 0.2